Skip to main content
CND In the News

News Outlets Take Note of Major Developments at CND Life Sciences

By April 17, 2023April 18th, 2023No Comments

News Outlets Take Note of Major Developments at CND Life Sciences

The last two weeks brought important milestones for CND Life Sciences, and several news outlets are taking notice of major developments for the company.

KTVK-TV Good Morning Arizona featured CND’s new global headquarters in recognition of national Parkinson’s month. In the interview, CEO Rick Morello showed off the new state-of-the-art lab and Chief Medical Officer and Co-Founder Dr. Todd Levine explained the benefits of the Syn-One Test®. CND chose the Pima Center in Scottsdale, Arizona for its headquarters in part because it can accommodate future growth and offers opportunities for collaboration with the scientific community.

The Phoenix Business Journal also highlighted the company’s fundraising success, noting the three NIH grants it received in the past year and the more than $12 million it has raised in equity from private and public investors. “We are likely to do a Series A financing by the end of the year and are excited about seeing the interest in continuing to fund our growth,” Morello was quoted in the article.

Read additional coverage from AZ Big Media, LabPulse, and Yahoo Finance.

CND Life Sciences

CND Life Sciences is the creator of the Syn-One Test™, the world’s first commercially available test to visualize abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test is an objective, evidence-based diagnostic tool to aid in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, or REM sleep behavior disorder.